{"version":"1.0","type":"link","title":"Association of RAS mutational status with clinical outcomes in metastatic colorectal cancer treated with trifluridine/tipiracil or regorafenib.","author_name":"Hsieh MC 외","author_url":"https://prs-insight.online/author/Hsieh%20MC","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/108326","thumbnail_width":1200,"thumbnail_height":630}